The	O
Correlation	O
of	O
Arterial	B:C0599949
Stiffness	I:C0599949
with	O
Biophysical	O
Parameters	O
and	O
Blood	O
Biochemistry	O
.	O

The	O
Correlation	O
of	O
Arterial	O
Stiffness	I:C0599949
with	O
Biophysical	O
Parameters	O
and	O
Blood	B:C0005767
Biochemistry	O
.	O

Type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
presents	O
with	O
numerous	O
macrovascular	O
and	O
microvascular	O
impairments	I:C0042373
,	O
which	O
in	O
turn	O
lead	O
to	O
various	O
co-morbidities	O
.	O

Type	O
2	I:C0011860
diabetes	I:C0011860
presents	O
with	O
numerous	O
macrovascular	B:C0042373
and	O
microvascular	O
impairments	I:C0042373
,	O
which	O
in	O
turn	O
lead	O
to	O
various	O
co-morbidities	O
.	O

Type	O
2	I:C0011860
diabetes	I:C0011860
presents	O
with	O
numerous	O
macrovascular	O
and	O
microvascular	B:C0042373
impairments	I:C0042373
,	O
which	O
in	O
turn	O
lead	O
to	O
various	O
co-morbidities	O
.	O

Vascular	B:C0005847
co-morbidities	O
can	O
be	O
seen	O
when	O
examining	O
arterial	O
stiffness	I:C0599949
(	O
arterial	O
stiffness	I:C0599949
)	O
,	O
which	O
is	O
a	O
predictor	O
for	O
endothelial	O
health	O
and	O
cardiovascular	O
disease	I:C0007222
risk	O
.	O

Vascular	O
co-morbidities	O
can	O
be	O
seen	O
when	O
examining	O
arterial	B:C0599949
stiffness	I:C0599949
(	O
arterial	O
stiffness	I:C0599949
)	O
,	O
which	O
is	O
a	O
predictor	O
for	O
endothelial	O
health	O
and	O
cardiovascular	O
disease	I:C0007222
risk	O
.	O

Vascular	O
co-morbidities	O
can	O
be	O
seen	O
when	O
examining	O
arterial	O
stiffness	I:C0599949
(	O
arterial	B:C0599949
stiffness	I:C0599949
)	O
,	O
which	O
is	O
a	O
predictor	O
for	O
endothelial	O
health	O
and	O
cardiovascular	O
disease	I:C0007222
risk	O
.	O

Vascular	O
co-morbidities	O
can	O
be	O
seen	O
when	O
examining	O
arterial	O
stiffness	I:C0599949
(	O
arterial	O
stiffness	I:C0599949
)	O
,	O
which	O
is	O
a	O
predictor	O
for	O
endothelial	B:C0014257
health	O
and	O
cardiovascular	O
disease	I:C0007222
risk	O
.	O

Vascular	O
co-morbidities	O
can	O
be	O
seen	O
when	O
examining	O
arterial	O
stiffness	I:C0599949
(	O
arterial	O
stiffness	I:C0599949
)	O
,	O
which	O
is	O
a	O
predictor	O
for	O
endothelial	O
health	O
and	O
cardiovascular	B:C0007222
disease	I:C0007222
risk	O
.	O

Pulse	B:C3494430
wave	I:C3494430
analysis	I:C3494430
(	O
Pulse	O
wave	I:C3494430
analysis	I:C3494430
)	O
and	O
pulse	O
wave	O
velocity	O
(	O
PWV	O
)	O
are	O
two	O
tests	O
that	O
are	O
commonly	O
used	O
to	O
measure	O
arterial	O
stiffness	I:C0599949
.	O

Pulse	O
wave	I:C3494430
analysis	I:C3494430
(	O
Pulse	B:C3494430
wave	I:C3494430
analysis	I:C3494430
)	O
and	O
pulse	O
wave	O
velocity	O
(	O
PWV	O
)	O
are	O
two	O
tests	O
that	O
are	O
commonly	O
used	O
to	O
measure	O
arterial	O
stiffness	I:C0599949
.	O

Pulse	O
wave	I:C3494430
analysis	I:C3494430
(	O
Pulse	O
wave	I:C3494430
analysis	I:C3494430
)	O
and	O
pulse	O
wave	O
velocity	O
(	O
PWV	O
)	O
are	O
two	O
tests	O
that	O
are	O
commonly	O
used	O
to	O
measure	O
arterial	B:C0599949
stiffness	I:C0599949
.	O

Currently	O
,	O
disease	B:C3887610
states	I:C3887610
and	O
progression	O
are	O
tracked	O
via	O
blood	O
biochemistry	O
.	O

Currently	O
,	O
disease	O
states	I:C3887610
and	O
progression	B:C0242656
are	O
tracked	O
via	O
blood	O
biochemistry	O
.	O

Currently	O
,	O
disease	O
states	I:C3887610
and	O
progression	O
are	O
tracked	O
via	O
blood	B:C0005767
biochemistry	O
.	O

These	O
gold	O
standards	O
in	O
monitoring	B:C1283169
diabetes	O
are	O
expensive	O
and	O
need	O
optimization	O
.	O

These	O
gold	O
standards	O
in	O
monitoring	O
diabetes	B:C0011847
are	O
expensive	O
and	O
need	O
optimization	O
.	O

These	O
gold	O
standards	O
in	O
monitoring	O
diabetes	O
are	O
expensive	B:C0243095
and	O
need	O
optimization	O
.	O

To	O
investigate	O
which	O
biophysical	O
and	O
biochemical	O
parameters	O
correlated	O
best	O
with	O
arterial	B:C0599949
stiffness	I:C0599949
,	O
which	O
may	O
reduce	O
the	O
number	O
of	O
biochemical	O
tests	I:C0430027
and	O
biophysical	O
parameter	O
measurements	O
needed	O
to	O
track	O
disease	O
progression	I:C0242656
.	O

To	O
investigate	O
which	O
biophysical	O
and	O
biochemical	O
parameters	O
correlated	O
best	O
with	O
arterial	O
stiffness	I:C0599949
,	O
which	O
may	O
reduce	O
the	O
number	O
of	O
biochemical	B:C0430027
tests	I:C0430027
and	O
biophysical	O
parameter	O
measurements	O
needed	O
to	O
track	O
disease	O
progression	I:C0242656
.	O

To	O
investigate	O
which	O
biophysical	O
and	O
biochemical	O
parameters	O
correlated	O
best	O
with	O
arterial	O
stiffness	I:C0599949
,	O
which	O
may	O
reduce	O
the	O
number	O
of	O
biochemical	O
tests	I:C0430027
and	O
biophysical	O
parameter	O
measurements	O
needed	O
to	O
track	O
disease	B:C0242656
progression	I:C0242656
.	O

Data	O
from	O
42	O
subjects	O
with	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
for	O
≤	O
10	O
years	O
,	O
aged	O
40	O
-	O
70	O
years	O
,	O
were	O
analyzed	O
at	O
a	O
single	O
time	O
point	O
.	O

Data	O
from	O
42	O
subjects	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
for	O
≤	O
10	O
years	O
,	O
aged	O
40	O
-	O
70	O
years	O
,	O
were	O
analyzed	B:C0936012
at	O
a	O
single	O
time	O
point	O
.	O

We	O
investigated	O
various	O
blood	B:C0005767
biochemistry	O
,	O
body	O
composition	O
,	O
and	O
arterial	O
stiffness	I:C0599949
parameters	O
.	O

We	O
investigated	O
various	O
blood	O
biochemistry	O
,	O
body	O
composition	O
,	O
and	O
arterial	B:C0599949
stiffness	I:C0599949
parameters	O
.	O

A	O
combination	O
of	O
fat	O
mass	O
and	O
fat	B:C0424679
-	I:C0424679
free	I:C0424679
mass	I:C0424679
was	O
most	O
associated	O
with	O
Pulse	O
wave	I:C3494430
analysis	I:C3494430
over	O
any	O
other	O
parameters	O
.	O

A	O
combination	O
of	O
fat	O
mass	O
and	O
fat	O
-	I:C0424679
free	I:C0424679
mass	I:C0424679
was	O
most	O
associated	O
with	O
Pulse	B:C3494430
wave	I:C3494430
analysis	I:C3494430
over	O
any	O
other	O
parameters	O
.	O

Leptin	B:C0299583
and	O
high	O
-	O
sensitivity	O
C-	O
reactive	I:C0006560
protein	I:C0006560
seem	O
to	O
be	O
the	O
next	O
two	O
parameters	O
that	O
correlate	O
with	O
augmentation	O
index	O
.	O

Leptin	O
and	O
high	O
-	O
sensitivity	O
C-	B:C0006560
reactive	I:C0006560
protein	I:C0006560
seem	O
to	O
be	O
the	O
next	O
two	O
parameters	O
that	O
correlate	O
with	O
augmentation	O
index	O
.	O

No	O
other	O
parameters	O
had	O
strong	O
correlations	O
to	O
either	O
Pulse	B:C3494430
wave	I:C3494430
analysis	I:C3494430
or	O
PWV	O
values	O
.	O

Body	B:C0022885
composition	I:C0022885
methods	I:C0022885
seemed	O
to	O
be	O
better	O
predictors	O
of	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
patient	O
's	O
vascular	O
disease	I:C0042373
progression	O
.	O

Body	O
composition	I:C0022885
methods	I:C0022885
seemed	O
to	O
be	O
better	O
predictors	O
of	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
patient	O
's	O
vascular	O
disease	I:C0042373
progression	O
.	O

Body	O
composition	I:C0022885
methods	I:C0022885
seemed	O
to	O
be	O
better	O
predictors	O
of	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
patient	O
's	O
vascular	B:C0042373
disease	I:C0042373
progression	O
.	O

Body	O
composition	I:C0022885
methods	I:C0022885
seemed	O
to	O
be	O
better	O
predictors	O
of	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
patient	O
's	O
vascular	O
disease	I:C0042373
progression	B:C0242656
.	O

Our	O
study	B:C2603343
indicates	O
that	O
body	O
composition	I:C1285593
measurements	I:C1285593
may	O
help	O
replace	O
expensive	O
tests	I:C0022885
.	O

Our	O
study	O
indicates	O
that	O
body	B:C1285593
composition	I:C1285593
measurements	I:C1285593
may	O
help	O
replace	O
expensive	O
tests	I:C0022885
.	O

Our	O
study	O
indicates	O
that	O
body	O
composition	I:C1285593
measurements	I:C1285593
may	O
help	O
replace	O
expensive	B:C0022885
tests	I:C0022885
.	O

This	O
may	O
have	O
public	B:C0699943
health	I:C0699943
and	O
health	O
surveillance	I:C3494318
implications	O
in	O
countries	O
facing	O
financial	O
challenges	I:C0549106
.	O

This	O
may	O
have	O
public	O
health	I:C0699943
and	O
health	B:C3494318
surveillance	I:C3494318
implications	O
in	O
countries	O
facing	O
financial	O
challenges	I:C0549106
.	O

This	O
may	O
have	O
public	O
health	I:C0699943
and	O
health	O
surveillance	I:C3494318
implications	O
in	O
countries	B:C0454664
facing	O
financial	O
challenges	I:C0549106
.	O

This	O
may	O
have	O
public	O
health	I:C0699943
and	O
health	O
surveillance	I:C3494318
implications	O
in	O
countries	O
facing	O
financial	B:C0549106
challenges	I:C0549106
.	O

